Abstract:BackgroundSpinal cord ischemia-reperfusion (I/R) involves two-phase injury, including an initial acute ischemic insult and subsequent inflammatory reperfusion injury, resulting in blood-spinal cord barrier (BSCB) dysfunction involving the TLR4 pathway. However, the correlation between TLR4/MyD88-dependent and TLR4/TRIF-dependent pathways in BSCB dysfunction is not fully understood. The aim of this study is to characterize inflammatory responses in spinal cord I/R and the events that define its clinical progression with delayed neurological deficits, supporting a bimodal mechanism of injury.MethodsRats were intrathecally pretreated with TAK-242, MyD88 inhibitory peptide, or Resveratrol at a 12 h interval for 3 days before undergoing 14-minute occlusion of aortic arch. Evan’s Blue (EB) extravasation and water content were detected at 6, 12, 18, 24, 36, 48, and 72 h after reperfusion. EB extravasation, water content, and NF-κB activation were increased with time after reperfusion, suggesting a bimodal distribution, as maximal increasing were detected at both 12 and 48 h after reperfusion. The changes were directly proportional to TLR4 levels determined by Western blot. Double-labeled immunohistochemical analysis was also used to detect the relationship between different cell types of BSCB with TLR4. Furthermore, NF-κB and IL-1β were analyzed at 12 and 48 h to identify the correlation between MyD88-dependent and TRIF-dependent pathways.ResultsRats without functional TLR4 and MyD88 attenuated BSCB leakage and inflammatory responses at 12 h, suggesting the ischemic event was largely mediated by MyD88-dependent pathway. Similar protective effects observed in rats with depleted TLR4, MyD88, and TRIF receptor at 48 h infer that the ongoing inflammation which occurred in late phase was mainly initiated by TRIF-dependent pathway and such inflammatory response could be further amplified by MyD88-dependent pathway. Additionally, microglia appeared to play a major role in early phase of inflammation after I/R injury, while in late responding phase both microglia and astrocytes were necessary.ConclusionsThese findings indicate the relevance of TLR4/MyD88-dependent and TLR4/TRIF-dependent pathways in bimodal phases of inflammatory responses after I/R injury, corresponding with the clinical progression of injury and delayed onset of symptoms. The clinical usage of TLR4 signaling inhibitors at different phases may be a therapeutic option for the prevention of delayed injury.

Early Blockade of TLRs MyD88-Dependent Pathway May Reduce Secondary Spinal Cord Injury in the Rats

Spinal Cord Decompression Reduces Rat Neural Cell Apoptosis Secondary to Spinal Cord Injury

The role of thrombospondin-1 and transforming growth factor-β after spinal cord injury in the rat

Inhibition of TLR4 Signalling-Induced Inflammation Attenuates Secondary Injury after Diffuse Axonal Injury in Rats

Dl‐3‐n‐butylphthalide Attenuates Acute Inflammatory Activation in Rats with Spinal Cord Injury by Inhibiting Microglial TLR4/NF‐κB Signalling

Role of the TLR4 pathway in blood-spinal cord barrier dysfunction during the bimodal stage after ischemia/reperfusion injury in rats

P2Y12 Receptor Mediates Apoptosis and Demyelination to Affect Functional Recovery in Mice with Spinal Cord Injury.

Involvement of Toll Like Receptor 2 Signaling in Secondary Injury During Experimental Diffuse Axonal Injury in Rats

A Possible Role of Rhoa/Rho-Kinase in Experimental Spinal Cord Injury in Rat

Triptolide Promotes the Repair of Spinal Cord Injury by Inhibiting Autophagy in Rats Models

A Novel Role Of Phospholipase A(2) In Mediating Spinal Cord Secondary Injury

Change of Toll-like receptor 4 expression in microglial cells after spinal cord compression injury in rats

The toll-like receptor 2 agonist Pam3CSK4 is neuroprotective after spinal cord injury

Targeting the NLRP3 Inflammasome to Attenuate Spinal Cord Injury in Mice

Genetic ablation of toll-like receptor 2 reduces secondary brain injury caused by cortical contusion in mice.

Inhibition of IL1R1 or CASP4 attenuates spinal cord injury through ameliorating NLRP3 inflammasome-induced pyroptosis

Different TLR4 Expression and Microglia/macrophage Activation Induced by Hemorrhage in the Rat Spinal Cord after Compressive Injury.

The Effects of Dexmedetomidine Pretreatment on the Pro- and Anti-Inflammation Systems after Spinal Cord Injury in Rats

Author Correction: Inhibition of Myeloid Differentiation Primary Response Protein 88 Provides Neuroprotection in Early Brain Injury Following Experimental Subarachnoid Haemorrhage

Expression of myeloid differentiation primary response protein 88 (Myd88) in the cerebral cortex after experimental traumatic brain injury in rats.

Inhibition of Myeloid Differentiation Factor 88(myd88) by ST2825 Provides Neuroprotection after Experimental Traumatic Brain Injury in Mice.